Go Pro

Novogen (KZIA) 10K Form and Latest SEC Filings 2026

Novogen logo
$13.52 +0.31 (+2.35%)
Closing price 04:00 PM Eastern
Extended Trading
$13.55 +0.03 (+0.22%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Novogen SEC Filings & Recent Activity

Novogen (NASDAQ:KZIA) has submitted 368+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Novogen's financial statements. The most recent filing was a Form SCHEDULE 13G/A submitted on August 14, 2026.

Form 4
KAZIA THERAPEUTICS LTD Reports Ownership Change on Jul. 8, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

Novogen SEC Filing History

Browse Novogen's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/14/2026 8:05 PM
Ikarian Capital, LLC (1778253) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
07/08/2026 3:57 PM
APPLE ROBERT F (1054942) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:57 PM
Cain David (2125950) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:58 PM
Davidson Ebru (2135805) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:58 PM
Bonacorda Jeffrey (2115111) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:59 PM
Friend John E. II (1704021) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:59 PM
Coffey Steven R. S. (2121676) Reporting
Novogen (1075880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2026 5:47 PM
Novogen (1075880) Issuer
Rao Sudha (2132027) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2026 5:47 PM
Novogen (1075880) Issuer
Levine James E. (1463151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2026 5:52 PM
Novogen (1075880) Issuer
Levine James E. (1463151) Reporting
Form 3
Initial statement of beneficial ownership of securities  
06/03/2026 7:20 PM
Davidson Ebru (2135805) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
06/02/2026 8:00 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2026 8:01 AM
Novogen (1075880) Filer
Form 424B3
06/02/2026 8:02 AM
Novogen (1075880) Filer
Form 424B3
06/02/2026 8:03 AM
Novogen (1075880) Filer
Form 424B3
06/02/2026 8:04 AM
Novogen (1075880) Filer
Form 424B3
05/27/2026 9:31 AM
Chernett Jorey (2042077) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
05/26/2026 7:00 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2026 7:01 AM
Novogen (1075880) Filer
Form 424B3
05/26/2026 7:02 AM
Novogen (1075880) Filer
Form 424B3
05/26/2026 7:03 AM
Novogen (1075880) Filer
Form 424B3
05/26/2026 7:04 AM
Novogen (1075880) Filer
Form 424B3
05/19/2026 12:07 PM
Novogen (1075880) Issuer
Rao Sudha (2132027) Reporting
Form 3
Initial statement of beneficial ownership of securities  
04/27/2026 7:30 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2026 7:30 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2026 7:31 AM
Novogen (1075880) Filer
Form 424B3
04/15/2026 7:32 AM
Novogen (1075880) Filer
Form 424B3
04/15/2026 7:33 AM
Novogen (1075880) Filer
Form 424B3
04/15/2026 7:34 AM
Novogen (1075880) Filer
Form 424B3
04/13/2026 4:24 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/13/2026 4:25 PM
Novogen (1075880) Filer
Form 424B3
04/13/2026 4:25 PM
Novogen (1075880) Filer
Form 424B3
04/13/2026 4:25 PM
Novogen (1075880) Filer
Form 424B3
04/13/2026 4:26 PM
Novogen (1075880) Filer
Form 424B3
04/09/2026 4:24 PM
Friend John E. II (1704021) Reporting
Novogen (1075880) Issuer
Form 3/A
04/01/2026 8:20 AM
Cain David (2125950) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/31/2026 3:56 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2026 1:36 PM
Chernett Jorey (2042077) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
03/30/2026 7:30 PM
Alumni Capital LP (1912606) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
03/29/2026 11:15 PM
Novogen (1075880) Filer
Form EFFECT
03/30/2026 5:08 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
03/19/2026 4:14 PM
Novogen (1075880) Filer
Form 424B3
03/19/2026 4:17 PM
Novogen (1075880) Filer
Form 424B3
03/19/2026 4:19 PM
Novogen (1075880) Filer
Form 424B3
03/19/2026 4:09 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2026 4:12 PM
Novogen (1075880) Filer
Form 424B3
03/18/2026 6:18 PM
Coffey Steven R. S. (2121676) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 5:32 PM
Novogen (1075880) Issuer
Simpson Jeremy (2121674) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 5:35 PM
Friend John E. II (1704021) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 4:55 PM
Bonacorda Jeffrey (2115111) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 4:47 PM
APPLE ROBERT F (1054942) Reporting
Novogen (1075880) Issuer
Form 3
Initial statement of beneficial ownership of securities  
02/17/2026 4:47 PM
Ikarian Capital, LLC (1778253) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G
01/27/2026 7:20 AM
Novogen (1075880) Filer
Form 424B3
01/27/2026 7:22 AM
Novogen (1075880) Filer
Form 424B3
01/27/2026 7:23 AM
Novogen (1075880) Filer
Form 424B3
01/27/2026 7:25 AM
Novogen (1075880) Filer
Form 424B3
01/27/2026 7:10 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2026 3:00 PM
Novogen (1075880) Subject
Lynwood Capital Management Inc. (1846412) Filed by
Form SCHEDULE 13G
12/23/2025 4:27 PM
Novogen (1075880) Filer
Form 424B3
12/23/2025 4:27 PM
Novogen (1075880) Filer
Form 424B3
12/22/2025 11:15 PM
Novogen (1075880) Filer
Form EFFECT
12/22/2025 11:15 PM
Novogen (1075880) Filer
Form EFFECT
12/19/2025 3:44 PM
Novogen (1075880) Filer
Form F-1
Registration statement for securities of certain foreign private issuers  
12/19/2025 3:45 PM
Novogen (1075880) Filer
Form F-1/A
12/19/2025 3:46 PM
Novogen (1075880) Filer
Form POS AM
12/19/2025 3:46 PM
Novogen (1075880) Filer
Form POS AM
12/19/2025 3:01 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2025 1:21 PM
Novogen (1075880) Filer
Form D
Notice of Exempt Offering of Securities 
12/10/2025 3:11 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2025 3:05 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2025 3:05 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2025 3:18 PM
Novogen (1075880) Filer
Form 424B3
11/18/2025 3:19 PM
Novogen (1075880) Filer
Form 424B3
11/18/2025 3:20 PM
Novogen (1075880) Filer
Form 424B3
11/14/2025 11:48 AM
Dauntless Investment Group, LLC (2044285) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
10/31/2025 3:01 PM
Novogen (1075880) Filer
Form NT 20-F
10/07/2025 4:17 PM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2025 4:19 PM
Novogen (1075880) Filer
Form 424B3
10/07/2025 4:22 PM
Novogen (1075880) Filer
Form 424B3
10/07/2025 4:24 PM
Novogen (1075880) Filer
Form 424B3
10/02/2025 7:55 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2025 7:58 AM
Novogen (1075880) Filer
Form 424B3
10/02/2025 8:01 AM
Novogen (1075880) Filer
Form 424B3
10/02/2025 8:04 AM
Novogen (1075880) Filer
Form 424B3
09/30/2025 7:00 AM
Novogen (1075880) Filer
Form F-1
Registration statement for securities of certain foreign private issuers  
09/12/2025 5:52 AM
Alumni Capital LP (1912606) Filed by
Novogen (1075880) Subject
Form SCHEDULE 13G/A
09/11/2025 8:23 AM
Novogen (1075880) Filer
Form 424B3
09/11/2025 8:11 AM
Novogen (1075880) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2025 8:18 AM
Novogen (1075880) Filer
Form 424B3
09/11/2025 8:20 AM
Novogen (1075880) Filer
Form 424B3
08/14/2025 1:57 PM
Novogen (1075880) Filer
Form D
Notice of Exempt Offering of Securities 
AI insiders stockpile guns, gold & gas masks (Ad)

Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift in the AI market is approaching, and time is short to prepare. Kaplan points to August 31st as a key turning point for AI investing. He argues the next phase will separate winners from losers, and reveals what he's watching instead of big names like Nvidia.tc pixel

See Keith Kaplan's full AI market briefing before August 31st
(Data available from 1/1/2016 forward)

Novogen SEC Filings - Frequently Asked Questions

Novogen (KZIA) has submitted 368+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Novogen's fiscal year ends on June 30. The company typically files its 10-K annual report by the end of August, covering the prior fiscal year's financial results. Key financial data from these reports is available on Novogen's financial statements page.

The most recent filing was a Form SCHEDULE 13G/A submitted on August 14, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:KZIA) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners